ChromaDex Corporation

ChromaDex leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. In addition to our ingredient technologies unit, we also have business units focused on natural product fine chemicals (known as “phytochemicals”), chemistry and analytical testing services, and product regulatory and safety consulting (known as Spherix Consulting). As a result of our relationships with leading universities and research institutions, we are able to discover and license early stage, IP-backed ingredient technologies. We then utilize our in-house chemistry, regulatory and safety consulting business units to develop commercially viable ingredients. Our ingredient portfolio is backed with clinical and scientific research, as well as extensive IP protection. Our portfolio of patented ingredient technologies includes NIAGEN® nicotinamide riboside; IMMULINA™, a spirulina extract; and AnthOrigin™, anthocyanins derived from a domestically-produced, water-extracted purple corn.

Bank Name ChromaDex Corporation
Stock Exchange NASDAQ
Symbol CDXC
Sector Healthcare
Industry Specialty Chemicals
Country United States
World Region America
Chairman
CEO Mr. Frank Louis Jaksch Jr
Employees 71
Website www.chromadex.com
Registered Year

 

UpdateContent
UpdateContent
UpdateContent